100 related articles for article (PubMed ID: 22569408)
41. GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas.
Marcus C; Maragkos GA; Alterman RL; Uhlmann E; Pihan G; Varma H
J Clin Neurosci; 2021 Jan; 83():49-55. PubMed ID: 33339691
[TBL] [Abstract][Full Text] [Related]
42. Intratumoral FOXP3+ Regulatory T Cells in Diffuse Large B-Cell Lymphoma.
Serag El-Dien MM; Abdou AG; Asaad NY; Abd El-Wahed MM; Kora MAEM
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):534-542. PubMed ID: 26862953
[TBL] [Abstract][Full Text] [Related]
43. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
[TBL] [Abstract][Full Text] [Related]
44. [Clinicopathologic features of breast lymphoma in core needle biopsy].
Rao J; Ruan M; Yu BH; Li XQ; Yang WT; Shui RH
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):737-742. PubMed ID: 30317726
[No Abstract] [Full Text] [Related]
45. Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype.
Sun J; Zhang J; Ling Q; Luo Y; Wu S; Liang Z; Zhong D; Zeng X
Virchows Arch; 2015 Jan; 466(1):93-100. PubMed ID: 25403088
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathologic analysis of localized nasal/paranasal diffuse large B-cell lymphoma.
Toda H; Sato Y; Takata K; Orita Y; Asano N; Yoshino T
PLoS One; 2013; 8(2):e57677. PubMed ID: 23469048
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma.
Hwang HS; Yoon DH; Suh C; Park CS; Huh J
Blood Res; 2013 Dec; 48(4):266-73. PubMed ID: 24466551
[TBL] [Abstract][Full Text] [Related]
48. Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas.
Gaudio F; Tamma R; Ingravallo G; Perrone T; Laddaga FE; De Candia M; Maiorano E; Ribatti D; Specchia G
Ann Hematol; 2018 Apr; 97(4):663-668. PubMed ID: 29362889
[TBL] [Abstract][Full Text] [Related]
49. Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell Lymphoma.
Xu Q; Tan C; Ni S; Wang Q; Wu F; Liu F; Ye X; Meng X; Sheng W; Du X
Sci Rep; 2015 May; 5():10006. PubMed ID: 25940947
[TBL] [Abstract][Full Text] [Related]
50. Genomic Analysis Reveals Distinct Subtypes in Two Rare Cases of Primary Ovarian Lymphoma.
Khattar P; Bedi P; Gonzalez M; Zhong M; Yin C; Huang W; Islam HK; Fallon JT
Pathol Res Pract; 2018 Apr; 214(4):593-598. PubMed ID: 29519565
[TBL] [Abstract][Full Text] [Related]
51. [Advances in the Molecular Diagnosis and Therapy of Relapsed/Refractory Diffuse Large B-cell Lymphoma -Review].
Wang Y; Xia B; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):603-608. PubMed ID: 29665940
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the algorithms classifying the ABC and GCB subtypes in diffuse large B-cell lymphoma.
Boltežar L; Prevodnik VK; Perme MP; Gašljević G; Novaković BJ
Oncol Lett; 2018 May; 15(5):6903-6912. PubMed ID: 29731865
[TBL] [Abstract][Full Text] [Related]
53. WHO reclassification of breast lymphomas.
Loughrey MB; Windrum P; Catherwood MA; Alexander HD; Markey GM; McManus DT; Morris TC
J Clin Pathol; 2004 Nov; 57(11):1213-4. PubMed ID: 15509687
[TBL] [Abstract][Full Text] [Related]
54. Clinico-Pathologic Profile and Treatment Outcomes of Patients with Diffuse Large B Cell Lymphoma Based on Cell of Origin Classification.
Mandloi SS; Thumaty DB; Nisha Y; Kayal S; Ganesan P; Jacob SE; Basu D; Dubashi B
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):226-231. PubMed ID: 33867728
[TBL] [Abstract][Full Text] [Related]
55. Primary central nervous system lymphoma: prognostication as per international extranodal lymphoma study group score and reactive CD3 collar.
Kumari N; Krishnani N; Rawat A; Agarwal V; Lal P
J Postgrad Med; 2009; 55(4):247-51. PubMed ID: 20083869
[TBL] [Abstract][Full Text] [Related]
56. Molecular Subtypes, Apoptosis and Proliferation Status in Indonesian Diffuse Large B-Cell Lymphoma Cases.
Snak Y; Indrawati ; Widayati K; Arfian N; Anggorowati N
Asian Pac J Cancer Prev; 2018 Jan; 19(1):185-191. PubMed ID: 29373912
[TBL] [Abstract][Full Text] [Related]
57. Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.
Leivonen SK; Taskinen M; Cervera A; Karjalainen-Lindsberg ML; Delabie J; Holte H; Lehtonen R; Hautaniemi S; Leppä S
Blood Cancer J; 2017 Aug; 7(8):e596. PubMed ID: 28841210
[TBL] [Abstract][Full Text] [Related]
58. Diffuse large B-cell lymphoma of the breast: a distinct entity?
Bierman PJ; Villanueva ML; Armitage JO
Ann Oncol; 2008 Feb; 19(2):201-2. PubMed ID: 18187483
[No Abstract] [Full Text] [Related]
59. Quantitative image analysis in the assessment of diffuse large B-cell lymphoma.
Chabot-Richards DS; Martin DR; Myers OB; Czuchlewski DR; Hunt KE
Mod Pathol; 2011 Dec; 24(12):1598-605. PubMed ID: 21841768
[TBL] [Abstract][Full Text] [Related]
60. Synchronous diffuse large B cell lymphomas of the endometrium and breast: a staging dilemma.
Gleeson JP; Woods GB; Watson GA; Ryan J; Doyle E; Quinn F; O'Keane JC; McCaffrey JA
Ir J Med Sci; 2017 Nov; 186(4):867-873. PubMed ID: 28470353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
